Mohammed Asadullah Jahangir, Dibyalochan Mohanty, Amarendranath Choudhury & Syed Sarim Imam. 2023. Multifunctional And Targeted Theranostic Nanomedicines. Multifunctional And Targeted Theranostic Nanomedicines
49
76
.
Prakash Kumar, Pawan Kumar, Nidhi Singh, Salil Khajuria, Rahul Patel, Vinod Kumar Rajana, Debabrata Mandal & Ravichandiran Velayutham. (2022) Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Zeynep Islek, Mehmet Hikmet Ucisik, Elif Keskin, Bilgesu Onur Sucu, Ana G. Gomes‐Alves, Ana M. Tomás, Mustafa Guzel & Fikrettin Sahin. (2022) Antileishmanial Activity of BNIPDaoct- and BNIPDanon-loaded Emulsomes on Leishmania infantum Parasites. Frontiers in Nanotechnology 3.
Crossref
Anushka Tyagi, Atul Pathak, Yashwant V. Pathak & Swati Gupta. 2022. Macrophage Targeted Delivery Systems. Macrophage Targeted Delivery Systems
225
252
.
Mehmet Hikmet ÜÇIŞIK. (2021) Replacement of Extrusion by Temperature-Controlled Ultrasonication in Emulsome Production. European Journal of Science and Technology.
Crossref
Rakhee Kapadia, Kinjal Parikh, Mahendra Jain & Krutika Sawant. (2020) Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies. Drug Delivery and Translational Research 11:3, pages 984-999.
Crossref
Giuliana Muraca, Ignacio Rivero Berti, María L. Sbaraglini, Wagner J. Fávaro, Nelson Durán, Guillermo R. Castro & Alan Talevi. (2020) Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers. Frontiers in Chemistry 8.
Crossref
Mohammad Imani & Azam Dehghan. 2020. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment
295
357
.
Pankaj Kumar Singh, Bapi Gorain, Hira Choudhury, Sachin Kumar Singh, Pankaj Whadwa, Shilpa, Sanjeev Sahu, Monica Gulati & Prashant Kesharwani. (2020) Macrophage targeted amphotericin B nanodelivery systems against visceral leishmaniasis. Materials Science and Engineering: B 258, pages 114571.
Crossref
Santanu Sasidharan & Prakash Saudagar. 2020. Encapsulation of Active Molecules and Their Delivery System. Encapsulation of Active Molecules and Their Delivery System
323
342
.
Viswanathan A. Aparna, Raja Biswas & R. Jayakumar. 2019. Biomimetic Nanoengineered Materials for Advanced Drug Delivery. Biomimetic Nanoengineered Materials for Advanced Drug Delivery
169
185
.
Vandana Soni, Silki Chandel, Vikas Pandey, Saket Asati, Priyanka Jain, Aviral Jain & Rakesh K. Tekade. 2019. Biomaterials and Bionanotechnology. Biomaterials and Bionanotechnology
263
300
.
Daniel A. Abugri, Joseph A. Ayariga, Boniface J. Tiimob, Clement G. Yedjou, Frank Mrema & William H. Witola. 2019. Medicinal Mushrooms. Medicinal Mushrooms
251
273
.
Gul Shahnaz, Hafiz Shoaib Sarwar & Masoom Yasinzai. 2018. Leishmaniases as Re-emerging Diseases. Leishmaniases as Re-emerging Diseases.
Niranjan G. Kotla, Bhargavi Chandrasekar, Peadar Rooney, Gandhi Sivaraman, Aitor Larrañaga, K. Vijaya Krishna, Abhay Pandit & Yury Rochev. (2017) Biomimetic Lipid-Based Nanosystems for Enhanced Dermal Delivery of Drugs and Bioactive Agents. ACS Biomaterials Science & Engineering 3:7, pages 1262-1272.
Crossref
Swati Pund & Amita Joshi. 2017. Nano- and Microscale Drug Delivery Systems. Nano- and Microscale Drug Delivery Systems
439
480
.
Lalit Kumar, Shivani Verma, Bhuvaneshwar Vaidya & Neelesh K. Mehra. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy
293
324
.
Naseem Akhtar & Riaz A. Khan. (2016) Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'. Progress in Lipid Research 64, pages 192-230.
Crossref
Sanketkumar Pandya, Rahul Kumar Verma, Prashant Khare, Brajendra Tiwari, Dadi A. Srinivasarao, Anuradha Dube, Neena Goyal & Amit Misra. (2016) Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B. International Journal for Parasitology: Drugs and Drug Resistance 6:2, pages 125-132.
Crossref
Yurui Xu, Sajid Asghar, Hongying Li, Minglei Chen, Zhigui Su, Yangfan Xu, Qineng Ping & Yanyu Xiao. (2016) Preparation of a paclitaxel-loaded cationic nanoemulsome and its biodistribution via direct intratumoral injection. Colloids and Surfaces B: Biointerfaces 142, pages 81-88.
Crossref
Xiaodan Zhou & Zhipeng Chen. (2015) Preparation and performance evaluation of emulsomes as a drug delivery system for silybin. Archives of Pharmacal Research 38:12, pages 2193-2200.
Crossref
Pramod K. Gupta, Anil K. Jaiswal, Vivek Kumar, Ashwni Verma, Pankaj Dwivedi, Anuradha Dube & Prabhat R. Mishra. (2014) Covalent Functionalized Self-Assembled Lipo-Polymerosome Bearing Amphotericin B for Better Management of Leishmaniasis and Its Toxicity Evaluation. Molecular Pharmaceutics 11:3, pages 951-963.
Crossref
Shardool Jain & Mansoor Amiji. 2014. Mucosal Delivery of Biopharmaceuticals. Mucosal Delivery of Biopharmaceuticals
283
312
.
Masoom YasinzaiMomin Khan, Akhtar Nadhman & Gul Shahnaz. (2013) Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. Future Medicinal Chemistry 5:15, pages 1877-1888.
Crossref
Shalini Asthana, Anil K. Jaiswal, Pramod K. Gupta, Vivek K. Pawar, Anuradha Dube & Manish K. Chourasia. (2013) Immunoadjuvant Chemotherapy of Visceral Leishmaniasis in Hamsters Using Amphotericin B-Encapsulated Nanoemulsion Template-Based Chitosan Nanocapsules. Antimicrobial Agents and Chemotherapy 57:4, pages 1714-1722.
Crossref
Philippe M. Loiseau & Gillian Barratt. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
321
350
.
Abeer H.A. Mohamed-Ahmed, Stephen Brocchini & Simon L. Croft. (2012) Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis. Current Opinion in Infectious Diseases 25:6, pages 695-702.
Crossref
Swati Gupta & Pankaj Kumar. (2012) Drug Delivery Using Nanocarriers: Indian Perspective. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 82:S1, pages 167-206.
Crossref
Dinesh Kumar, Deepak Sharma, Gurmeet Singh, Mankaran Singh & Mahendra Singh Rathore. (2012) Lipoidal Soft Hybrid Biocarriers of Supramolecular Construction for Drug Delivery. ISRN Pharmaceutics 2012, pages 1-14.
Crossref
Fernando Leal-Calderon & Maud Cansell. (2012) The design of emulsions and their fate in the body following enteral and parenteral routes. Soft Matter 8:40, pages 10213.
Crossref
Shardool Jain & Mansoor Amiji. 2012. Multifunctional Nanoparticles for Drug Delivery Applications. Multifunctional Nanoparticles for Drug Delivery Applications
47
83
.
Leonid Kagan, Pavel Gershkovich, Kishor M. Wasan & Donald E. Mager. (2011) Physiologically Based Pharmacokinetic Model of Amphotericin B Disposition in Rats Following Administration of Deoxycholate Formulation (Fungizone®): Pooled Analysis of Published Data. The AAPS Journal 13:2.
Crossref
Samir Das, Wahid Khan, Shaikh Mohsin & Neeraj Kumar. (2010)
Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and
in vitro
evaluation
. Polymers for Advanced Technologies 22:1, pages 172-179.
Crossref
Helena C. Maltezou. (2010) Drug Resistance in Visceral Leishmaniasis. Journal of Biomedicine and Biotechnology 2010, pages 1-8.
Crossref